|
Market Closed -
Nasdaq
16:00:00 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 9.340 USD | -2.61% |
|
+3.78% | +14.18% |
| 10-27 | Wedbush Adjusts Price Target on ORIC Pharmaceuticals to $14 From $17, Keeps Outperform Rating | MT |
| 10-23 | ORIC Pharmaceuticals, Inc. - Special Call |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ORIC | Delayed | |
CBOE
| ORIC | Real-time | |
|
Deutsche Boerse AG
| 4TZ | Delayed | |
|
Börse Stuttgart
| 4TZ | Delayed | |
|
Tradegate
| 4TZ | Real-time | |
|
Boerse Muenchen
| 4TZ | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 11.31 | 14.65 | 14.2 |
| Spread/Res. | -17.42% | -36.25% | -34.23% |
| Spread/Supp. | +4.30% | +24.53% | +24.53% |
| Support | 8.955 | 7.5 | 7.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORIC Stock
- Charts ORIC Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
